Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Leukemia 16Carcinoma, Renal Cell 15Leukemia, Myeloid, Chronic-Phase 13Kidney Neoplasms 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Melanoma 8Multiple Myeloma 7Pancreatic Neoplasms 6Lymphoma 6Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Neoplasms 4Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Acute 4Leukemia, Myeloid, Accelerated Phase 4Carcinoma, Hepatocellular 4Waldenstrom Macroglobulinemia 3Urinary Bladder Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Lymphocytic, Chronic, B-Cell 3Stomach Neoplasms 2Skin Neoplasms 2Recurrence 2Polycythemia Vera 2Lymphoma, B-Cell, Marginal Zone 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Cisplatin 86Radiotherapy 71Paclitaxel 50Fluorouracil 38Carboplatin 36Drug Therapy 32Neoadjuvant Therapy 23toripalimab 19tislelizumab 18pembrolizumab 17camrelizumab 17Irinotecan 17Esophagectomy 17Surgical Procedures, Operative 16Radiation 16Docetaxel 16sintilimab 15Oxaliplatin 14130-nm albumin-bound paclitaxel 14nimotuzumab 11TP protocol 11S 1 (combination) 11Radiotherapy, Intensity-Modulated 11Cetuximab 11Capecitabine 11Albumin-Bound Paclitaxel 10apatinib 9Leucovorin 9Immune Checkpoint Inhibitors 8nedaplatin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Esophageal Squamous Cell Carcinoma × Interferon-alpha × Clear all
NCT00004897 2012-06-12

Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer

Northwestern University

Phase 2 Terminated
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00002506 2011-05-12

Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer

Hoag Memorial Hospital Presbyterian

Phase 2 Completed
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Penile Neoplasms, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡